Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.

about

A field guide for cancer diagnostics using cell-free DNA: From principles to practice and clinical applications.Overview on Clinical Relevance of Intra-Tumor Heterogeneity.

P2860

Q48178985-1F0ADF85-98EF-497D-81EE-4894BEF817E1 Q52313049-14DDD21D-EDB2-4A7F-B891-4C6124DF975F

P2860

Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.

Item

http://www.wikidata.org/entity/Q38683041

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Spatial distribution of EGFR a ...... terns of lung adenocarcinomas.

@en

type

Item

label

Spatial distribution of EGFR a ...... terns of lung adenocarcinomas.

@en

prefLabel

Spatial distribution of EGFR a ...... terns of lung adenocarcinomas.

@en

P1476

Spatial distribution of EGFR a ...... terns of lung adenocarcinomas.

@en

P2093

Albrecht Stenzinger

http://www.w3.org/2001/XMLSchema#string

Alexander Harms

http://www.w3.org/2001/XMLSchema#string

Daniel Kazdal

http://www.w3.org/2001/XMLSchema#string

Florian Eichhorn

http://www.w3.org/2001/XMLSchema#string

Holger Sültmann

http://www.w3.org/2001/XMLSchema#string

Mark Kriegsmann

http://www.w3.org/2001/XMLSchema#string

Steffen Dietz

http://www.w3.org/2001/XMLSchema#string

Volker Endris

http://www.w3.org/2001/XMLSchema#string

P2860

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Comprehensive molecular profiling of lung adenocarcinoma.

Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.

Intratumoral distribution of EGFR mutations and copy number in metastatic lung cancer, what impact on the initial molecular diagnosis?

Detection and clinical significance of intratumoral EGFR mutational heterogeneity in Chinese patients with advanced non-small cell lung cancer.

Molecular diagnostic profiling of lung cancer specimens with a semiconductor-based massive parallel sequencing approach: feasibility, costs, and performance compared with conventional sequencing.

PIK3CA mutations frequently coexist with EGFR/KRAS mutations in non-small cell lung cancer and suggest poor prognosis in EGFR/KRAS wildtype subgroup

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients.

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection.

Coexistence of PIK3CA and other oncogene mutations in lung adenocarcinoma-rationale for comprehensive mutation profiling

P304

1841-1848

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/IJC.30881

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

141

http://www.w3.org/2001/XMLSchema#string

P50

Arne Warth

Rémi Longuespée

P577

2017-07-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28699162

http://www.w3.org/2001/XMLSchema#string

P921

adenocarcinoma

Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.

about

P2860

P2860

Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomas.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921